During a Chinese pavilion event on the sidelines of the 2024 Ministerial Conference on Nuclear Science, Technology and Applications and the Technical Cooperation Programme of the International Atomic Energy Agency (IAEA) in Austria's Vienna on November 26 local time, China National Nuclear Corporation(CNNC) formally unveiled China’s integrated solutions to nuclear technology applications concerning nuclear medicine and irradiation, and showed to the world China's experience and achievements in such fields as nuclear medicine, irradiation applications, medical isotopes and radiopharmaceutical production.

IAEA Director-General Rafael Mariano Grossi and IAEA Deputy Director-General Liu Hua attended the event and toured around an exhibition on the country's achievements in nuclear technology applications.

Those in attendance of the event also included Najat Mokhtar, deputy director-general of the IAEA; Qu Dongyu, director-general of the Food and Agriculture Organization of the United Nations (FAO); Zou Ciyong, deputy director-general of the Directorate of the United Nations Industrial Development Organization (UNIDO); Li Song, China's permanent representative to the UN and other international organizations in Vienna; Huang Ping, secretary-general of the China Atomic Energy Authority (CAEA); Wang Xuejun, chief accountant of the CNNC; representatives of Vienna-headquartered international agencies; senior officials from Russia, Cuba, Thailand, Syria, Sudan and Pakistan at the IAEA Ministerial Conference on Nuclear Science, Technology and Applications and the Technical Cooperation Programme; experts and media workers.

As an industrial leader in the promotion of nuclear technology applications in China, the CNNC has built extensive expertise in nuclear medicine and irradiation over the years. It has developed integrated service solutions, which cover the R&D and sales of isotope, and special nuclear medicine services, and provided its global clients with such services as project design and construction together with equipment installation and testing.

In addition, the CNNC exhibited the world's first X-ray and gamma-ray (X/γ) radiation dose detection chip. Thanks to its compact size and high sensitivity, the homegrown X/γ radiation dose detection chip boasts tremendous application potentials in a wide range of fields, especially in smart devices with radiation detection capabilities. It can be easily installed into smartphones and other intelligent equipment. With manual-guided secondary software development, it is expected to be widely used in the detection of radiation dose for nuclear-related workplaces, personnel and environmental scenarios.

During the meeting, the China Isotope & Radiation Association signed agreements with the IAEA over radioisotope and radiation processing to further deepen bilateral exchanges and cooperation in nuclear technology applications. Experts from the China Isotope & Radiation Corporation and the China Institute of Atomic Energy gave an introduction to the latest technological research progress and results made by the country in the research, development and production of medical isotopes, radiopharmaceuticals, nuclear medicine, radiation dose detection chip and irradiation manufacturing.

Furthermore, the CNNC integrated traditional Chinese culture and adopted physical display as well as interactive experiences to underscore its solutions for radiopharmaceuticals manufacturing facilities, smart nuclear medicine and radiotherapy center, intelligent radiation detection and integrated irradiation station.

Attendees said that they looked forward to engaging in closer communication and cooperation with the Chinese side over nuclear technology application in agricultural and medical sectors and working together for the realization of the UN 2030 Agenda for Sustainable Development.